1.800.979.8292

Pathology Laboratory Services

Serving more than 5,500 patients each day, Miraca Life Sciences is a leader in providing an academic-caliber clinical pathology laboratory with diagnostic services in the fields of dermatology, gastroenterology, hematology and urology. Building upon our experience with health IT, we also offer accessible EHR solutions to assist healthcare professionals as they work towards accordance with Meaningful Use initiatives.

Miraca Development Services focuses on providing specialty-specific, comprehensive pathology and laboratory services, as well as development and deployment services to pharmaceutical companies, contract research organizations, and diagnostic/molecular testing developers. A “one-stop shop” for all pathology and laboratory needs for clinical research and test validations, Miraca Development Services is the premier resource for lab testing, specialized pathology services, tissue procurement, and study design.

We employ a talented team of leading pathologists, histologists, lab technicians, technology consultants, and other medical professionals — all driven to help provide the highest and most up-to-date levels of diagnostic quality, enhanced workflow and practice solutions possible. It’s part of our commitment: not only to scientific excellence, but to you.

Pathology Research & Publications

Our skilled team of field-specific clinical pathologists, consultants and experts work diligently to stay at the forefront of the ever-changing landscape of a pathology laboratory and health IT. As part of this diligence, we work closely with one another to provide the highest quality, academic-based research and information possible.

Equip yourself with powerful information on specific conditions and diseases with Miraca Life Sciences. Learn More
Explore the growing library of Miraca Life Sciences webinars and discover expertise in motion. Learn More

Recent News


On UroToday.com: Miraca Research Highlighted

On November 4, UroToday.com featured a research abstract authored by Rajal Shah, MD, Director of Urologic Pathology for Miraca Life Sciences, and Yousef Tadros, MD FCAP FASCP, Director of Uropathology Quality Assurance. The abstract is titled Adenocarcinoma of the Prostate with Gleason Pattern 5 on Core Biopsy: Frequency of Diagnosis, Morphologic Subpatterns and Relation to Pattern Distribution Based on the Modified Gleason [...]


Miraca Holdings News: Joint Venture with Baylor College of Medicine for Clinical Genetic Testing

HOUSTON, October 31, 2014 — Baylor College of Medicine and Miraca Holdings Inc., today agreed on a joint venture in which the College will share ownership and governance of its clinical genetics diagnostic laboratories with the Japan-based international healthcare company that has a focus on clinical diagnostics and laboratory tests.

Baylor Miraca Genetics Laboratories will be built on Baylor’s existing [...]


Featured Subspecialty Expert


Saboorian

M.H. Saboorian, MD

Director of General Surgical Pathology and Cytology

more